<DOC>
	<DOC>NCT00664664</DOC>
	<brief_summary>This study is designed to compare 2 doses of APD125 (20 mg and 40 mg) with placebo in otherwise healthy adults with primary insomnia primarily with complaints of maintaining sleep. Participants will be required to maintain a daily sleep dairy for up to 3 weeks while on study.</brief_summary>
	<brief_title>Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<criteria>Men and women, ages 18 to 65 years Primary insomnia as defined in DSMIVTR, with predominant complaint of impaired sleep maintenance and confirmed by patient reported sleep diaries Generally good health History of any sleep disorder, other than primary insomnia (e.g., restless leg syndrome, narcolepsy, sleep apnea, and disorders of REM/NREM sleep) Any clinically significant medical condition, laboratory finding, or ECG finding Pregnant and/or lactating females History of substance abuse within 2 years or positive urine drug screen Positive Hepatitis B/C results or HIV markers History of treatment with an investigational drug within the last month Recent travel involving crossing more than 3 time zones or plans to travel to another time zone (&gt; 3 time zones) during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>insomnia</keyword>
	<keyword>sleep maintenance insomnia</keyword>
	<keyword>sleep quality</keyword>
	<keyword>non-restorative sleep</keyword>
	<keyword>multiple awakenings</keyword>
</DOC>